Context
According to the WHO, Ethiopia is one of the 56 countries with the highest prevalence of trachoma, an infectious conjunctivitis that can lead to blindness. Trachoma is also the second leading cause of blindness in the country. It is the Amhara region that suffers the most with a prevalence rate of 62.2% due to a lack of drinking water as well as precarious sanitary conditions. It is indeed facing a shortage of appropriate treatments and medicines.
Supported project
In 2018-2019, L'OCCITANE Italy and the L'OCCITANE Foundation supported CBM's project, which aimed at reducing the prevalence rate of Trachoma in the 3 districts of Sodo, Lanfuro and Dalocha (Selti areas) in Ethiopia. The goal was to prevent the infection that caused long-term blindness and to offer care services to those who were already infected by Trachoma through the implementation of the S.A.F.E strategy proposed by the WHO. The intervention in line with WHO was based on performing specific surgeries and on distributing antibiotics to the community.
Some figures
Budget 20,000 euros
Results 16,047 beneficiaries
Partnership history
Project supported since 2017
The Foundation L'OCCITANE and L'OCCITANE Italy has been supporting the CBM project to eliminate trachoma by 2020 in the districts of Sodo, Lanfuro and Dalocha in Ethiopia since 2017. The objective is to prevent the infection that causes blindness in the long term and to provide care services to those who are already infected with trachoma through the implementation of the S.A.F.E. strategy proposed by the WHO.
